2020 ; Vol.30-1: 54~61
|Author||Ji Eun Moon, Wan Heo, Sang Hoon Lee, Suk Hee Lee, Hong Gu Lee, Jin Hyup Lee, Young Jun Kim|
|Place of duty||Department of Food and Biotechnology, Korea University, Sejong 30019, Republic of Korea |
|Title||Trehalose Protects the Probiotic Yeast Saccharomyces boulardii against Oxidative Stress-Induced Cell Death|
J. Microbiol. Biotechnol.2020 ;
|Abstract||Saccharomyces boulardii is the only probiotic yeast with US Food and Drug Administration
approval. It is routinely used to prevent or treat acute diarrhea and other gastrointestinal
disorders, including the antibiotic-associated diarrhea caused by Clostridium difficile infections.
The formation of reactive oxygen species (ROS), specifically H2O2 during normal aerobic
metabolism, contributes to programmed cell death and represents a risk to the viability of the
probiotic microbe. Moreover, a loss of viability reduces the efficacy of the probiotic treatment.
Therefore, inhibiting the accumulation of ROS in the oxidant environment could improve the
viability of the probiotic yeast and lead to more efficacious treatment. Here, we provide
evidence that supplementation with a non-reducing disaccharide, namely trehalose, enhanced
the viability of S. boulardii exposed to an oxidative environment by preventing metacaspase
YCA1-mediated programmed cell death through inhibition of intracellular ROS production.
Our results suggest that supplementation with S. boulardii together with trehalose could
increase the viability of the organism, and thus improve its effectiveness as a probiotic and as
a treatment for acute diarrhea and other gastrointestinal disorders.|
|Key_word||Trehalose, probiotics, reactive oxygen species, programmed cell death|
Kechagia M, Basoulis D, Konstantopoulou S, Dimitriadi D, Gyftopoulou K, Skarmoutsou N, et al. 2013. Health benefits of probiotics: a review. ISRN Nutr. 2013: 481651.
Czerucka D, Piche T, Rampal P. 2007. Review article: yeast as probiotics -- Saccharomyces boulardii. Aliment. Pharmacol. Ther. 26: 767-778.
Dinleyici EC, Eren M, Ozen M, Yargic ZA, Vandenplas Y. 2012. Effectiveness and safety of Saccharomyces boulardii for acute infectious diarrhea. Expert Opin. Biol. Ther. 12: 395-410.
Pozzoni P, Riva A, Bellatorre AG, Amigoni M, Redaelli E, Ronchetti A, et al. 2012. Saccharomyces boulardii for the prevention of antibiotic-associated diarrhea in adult hospitalized patients: a single-center, randomized, double-blind, placebocontrolled trial. Am. J. Gastroenterol. 107: 922-931.
Sudha MR, Bhonagiri S, Kumar MA. 2012. Oral consumption of potential probiotic Saccharomyces boulardii strain Unique 28 in patients with acute diarrhoea: a clinical report. Benef. Microbes 3: 145-150.
Surawicz CM, McFarland LV, Greenberg RN, Rubin M, Fekety R, Mulligan ME, et al. 2000. The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clin. Infect. Dis. 31: 1012-1017.
Tung JM, Dolovich LR, Lee CH. 2009. Prevention of Clostridium difficile infection with Saccharomyces boulardii: a systematic review. Can. J. Gastroenterol. 23: 817-821.
Correa NB, Penna FJ, L ima FM, Nicoli JR, Filho L A. 2011. Treatment of acute diarrhea with Saccharomyces boulardii in infants. J. Pediatr. Gastroenterol. Nutr. 53: 497-501.
Dinleyici EC, Eren M, Yargic ZA, Dogan N, Vandenplas Y. 2009. Clinical efficacy of Saccharomyces boulardii and metronidazole compared to metronidazole alone in children with acute bloody diarrhea caused by amebiasis: a prospective, randomized, open label study. Am. J. Trop. Med. Hyg. 80: 953-955.
Kelesidis T, Pothoulakis C. 2012. Efficacy and safety of the probiotic Saccharomyces boulardii for the prevention and therapy of gastrointestinal disorders. Therap. Adv. Gastroenterol. 5: 111-125.
McFarland LV. 2010. Systematic review and meta-analysis of Saccharomyces boulardii in adult patients. World J. Gastroenterol. 16: 2202-2222.
Vandenplas Y, Brunser O, Szajewska H. 2009. Saccharomyces boulardii in childhood. Eur. J. Pediatr. 168: 253-265.
Jamieson DJ. 1998. Oxidative stress responses of the yeast Saccharomyces cerevisiae. Yeast 14: 1511-1527.
Mariani D, Mathias CJ, da Silva CG, Herdeiro Rda S, Pereira R, Panek AD, et al. 2008. Involvement of glutathione transferases, Gtt1and Gtt2, with oxidative stress response generated by H2O2 during growth of Saccharomyces cerevisiae. Redox Rep. 13: 246-254.
Perrone GG, Tan SX, Dawes IW. 2008. Reactive oxygen species and yeast apoptosis. Biochim. Biophys. Acta 1783: 1354-1368.
Jamieson DJ. 1995. The effect of oxidative stress on Saccharomyces cerevisiae. Redox Rep. 1: 89-95.
Benaroudj N, Lee DH, Goldberg AL. 2001. Trehalose accumulation during cellular stress protects cells and cellular proteins from damage by oxygen radicals. J. Biol. Chem. 276: 24261-24267.
Herdeiro RS, Pereira MD, Panek AD, Eleutherio EC. 2006. Trehalose protects Saccharomyces cerevisiae from lipid peroxidation during oxidative stress. Biochim. Biophys. Acta 1760: 340-346.
Alugoju P, Janardhanshetty SS, Subaramanian S, Periyasamy L, Dyavaiah M. 2018. Quercetin protects yeast Saccharomyces cerevisiae pep4 mutant from oxidative and apoptotic stress and extends chronological lifespan. Curr. Microbiol. 75: 519-530.
Cascio V, Gittings D, Merloni K, Hurton M, Laprade D, Austriaco N. 2013. S-Adenosyl-L-methionine protects the probiotic yeast, Saccharomyces boulardii, from acid-induced cell death. BMC Microbiol. 13: 35.
Dani C, Bonatto D, Salvador M, Pereira MD, Henriques JA, Eleutherio E. 2008. Antioxidant protection of resveratrol and catechin in Saccharomyces cerevisiae. J. Agric. Food Chem. 56: 4268-4272.
Martorell P, Forment JV, de Llanos R, Monton F, Llopis S, Gonzalez N, et al. 2011. Use of Saccharomyces cerevisiae and Caenorhabditis elegans as model organisms to study the effect of cocoa polyphenols in the resistance to oxidative stress. J. Agric. Food Chem. 59: 2077-2085.
Mendes V, Vilaca R, de Freitas V, Ferreira PM, Mateus N, Costa V. 2015. Effect of myricetin, pyrogallol, and phloroglucinol on yeast resistance to oxidative stress. Oxid. Med. Cell. Longev. 2015: 782504.
Luo Y, Li WM, Wang W. 2008. Trehalose: Protector of antioxidant enzymes or reactive oxygen species scavenger under heat stress? Environ. Exp. Bot. 63: 378-384.
Gao Z, Wang H, Zhang B, Wu X, Zhang Y, Ge P, Chi G, Liang J. 2018. Trehalose inhibits H2O2-induced autophagic death in dopaminergic SH-SY5Y cells via mitigation of ROSdependent endoplasmic reticulum stress and AMPK activation. Int. J. Med. Sci. 15: 1014–1024.
Mazzoni C, Falcone C. 2008. Caspase-dependent apoptosis in yeast. Biochim. Biophys. Acta 1783: 1320-1327.
Millard PJ, Roth BL, Thi HP, Yue ST, Haugland RP. 1997. Development of the FUN-1 family of fluorescent probes for vacuole labeling and viability testing of yeasts. Appl. Environ. Microbiol. 63: 2897-2905.
Madeo F, Frohlich E, L igr M, Grey M, Sigrist SJ, Wolf DH, et al. 1999. Oxygen stress: a regulator of apoptosis in yeast. J. Cell Biol. 145: 757-767.
Farrugia G, Balzan R. 2012. Oxidative stress and programmed cell death in yeast. Front. Oncol. 2: 64.
Izawa S, Inoue Y, Kimura A. 1995. Oxidative stress response in yeast: effect of glutathione on adaptation to hydrogen peroxide stress in Saccharomyces cerevisiae. FEBS Lett. 368: 73-76.
Madeo F, Frohlich E, Frohlich KU. 1997. A yeast mutant showing diagnostic markers of early and late apoptosis. J. Cell Biol. 139: 729-734.
Madeo F, Carmona-Gutierrez D, Ring J, Buttner S, Eisenberg T, Kroemer G. 2009. Caspase-dependent and caspase-independent cell death pathways in yeast. Biochem. Biophys. Res. Commun. 382: 227-231.
Burhans WC, Weinberger M, Marchetti MA, Ramachandran L, D’Urso G, Huberman JA. 2003. Apoptosis-like yeast cell death in response to DNA damage and replication defects. Mutat. Res. 532: 227-243.
Lefevre S, Sliwa D, Auchere F, Brossas C, Ruckenstuhl C, Boggetto N, et al. 2012. The yeast metacaspase is implicated in oxidative stress response in frataxin-deficient cells. FEBS Lett. 586: 143-148.
Treml J, Smejkal K. 2016. Flavonoids as Potent Scavengers of Hydroxyl Radicals. Compr. Rev. Food Sci. Food Saf. 15: 720-738.